trigger a FP7 EU collaborative project, periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies.
University of Birmingham

The University of Birmingham
B15 2TT
United Kingdom
‎ +44 (0)121 414 3344


Need help or have a question?

Call us for additional support with any questions surrounding the Trigger project.

0047-46- 610- 782



University of Birmingham, UK (BGHM)

Prof. R. Stockley heads the Lung Immunobiochemical research laboratory based at the University Hospital in Birmingham with co-located university research and clinical facilities. This new custom built facility brings the patient and state-of-the-art research facilities within a single site. Facilities are present to review and characterise patients with COPD in extensive detail including full physiological and radiological assessment, the characterisation of co-morbidities including Cardiovascular, diabetic and osteoporotic assessment as well as facilities to determine and sample the presence of periodontal disease in collaboration with Prof. I. Chappel (University of Birmingham). The research group has an international reputation in the pathophysiology of COPD with a particular interest in the role of inflammation and proteolytic enzymes. The group pioneered the development of quantitative microbiology in the assessment of airways inflammation and the nature of exacerbations of lung disease.

Team Members:

Robert Stockley, Prof., MD, DSc, FRCP

Elizabeth Sapey MD, PhD

Adam Usher, MD, MRCP

The TRIGGER consortium consists of 7 universities (UiB, UJ, AU, BHAM, UiO, HUMC, UB), 3 research centres (KI, CSIC, Fraunhofer) from a strong clinical and research environment, and SME (AX). All together we represent 7 EU countries and 2 associated Member States (Norway, Israel).